Search for a trial

A multi-centre, open-label, follow-on study to assess long-term safety and tolerability of intracerebroventricular administration of sNN0029 in patients with amyotrophic lateral sclerosis

The objective of the trial is to assess the long-term safety and tolerability of intracerebroventricular administration of sNN0029 infusion solution at a dose of 4 µg/day delivered via a Medtronic SynchroMed® II Infusion System.